The company’s ingredient production facilities in Mexico, the US, Europe and Asia have attained the distinction from the FDA and the European Federation for Cosmetic Ingredients.
The European Federation for Cosmetic Ingredients has protocol in place to safeguard the internal cosmetics market at a high level, making certain the industry does what it can to protect human health. This is, in turn, designed to ensure that the market continues to function.
The company received certification from the European regulatory body before it did from the US FDA. (See the Cosmetics Design article on that news here.)
US regulatory suggestions
The US Food and Drug Administration certification speaks to procedural protocols in place at cosmetic (ingredient) manufacturing facilities. It addresses issues of documentation and records keeping, building and equipment standards, personnel, raw materials, laboratory controls and more.
The ISO 22716 “is intended to assist industry and other stakeholders in identifying the standards and issues that can affect the quality of cosmetic products,” reads the document. The US FDA guidelines come from the body’s participation in the International Organization for Standardization (ISO), and the “FDA’s guidance documents, including this guidance, do not establish legally enforceable responsibilities.”
“Adherence to these standards ensures the highest quality products and production processes for the cosmetics and personal care industry” asserted the corporation’s press release.
Accordingly, Clariant customers are subject to the same regulations to compete successfully in the cosmetic manufacturing business. So the fact that Clariant has the FDA’s ISO 22716 certification for all U.S. cosmetics-ingredients sites, and the corporation's 22 dedicated cosmetics-ingredient sites in Europe, Asia, and Mexico have certification from the European Federation for Cosmetic Ingredients, simplifies procedures all along the production chain.
"For our customers, meeting this standard is no longer just a product benefit but has become a requirement of doing business," John Clarke, regional head, Clariant Industrial & Consumer Specialties Business – North America, told the press.
Brazilian biological actives
Recently Clariant invested in natural ingredient production, acquiring 30% share in Beraca. That company substantially increased its global reach by partnering with Clariant.
While “the investment with Beraca will enhance Clariant’s innovation capabilities in the field of natural ingredients for cosmetics and personal care applications and enlarge the range of valuable solutions we offer to customers and end consumers,” said Michael Willome, head of the industrial & consumer specialties business unit at Clariant, at the time of the purchase.